GRMN vs PTGX · P/E 28, rev $7.25B vs rev $269.8M
Garmin Ltd (GRMN) versus Protagonist Therapeutics Inc (PTGX) — a side-by-side from cached financials, not a winner call.
Garmin Ltd (GRMN) is a scientific & technical instruments company listed on US.
Protagonist Therapeutics Inc (PTGX) is a biotechnology company listed on NASDAQ.
Latest reported GRMN revenue for 2025-12-27 was $7.25B. Net income was $1.66B. Revenue was up 15.1% from 2024-12-28 to 2025-12-27. GRMN currently screens at market cap $41.35B and trailing P/E 28.3.
Latest reported PTGX revenue for 2026-06-30 was $269.8M. Net income was $166.6M. PTGX currently screens at market cap $7.25B.
GRMN currently screens at market cap $41.35B and trailing P/E 28.3. PTGX currently screens at market cap $7.25B.
Not investment advice. Open the GRMN and PTGX stock pages for the full models.
Not investment advice.